Patents Assigned to Seer, Inc.
  • Patent number: 12287331
    Abstract: Compositions, methods, and systems for analyzing the protein corona are described herein, as well as its application in the discovery of advanced diagnostic tools as well as therapeutic targets.
    Type: Grant
    Filed: September 1, 2023
    Date of Patent: April 29, 2025
    Assignee: Seer, Inc.
    Inventors: Hongwei Xia, Lyndal Hesterberg, Michael Figa, Xiaoyan Zhao, Gregory Troiano, William Manning, John Blume, Omid Farokhzad, Matthew McLean, Craig Stolarczyk, Marwin Ko, Theodore Platt
  • Patent number: 12276668
    Abstract: Disclosed herein are compositions and methods for assaying for proteins and nucleic acids, in parallel.
    Type: Grant
    Filed: February 24, 2023
    Date of Patent: April 15, 2025
    Assignee: Seer, Inc.
    Inventors: Daniel Hornburg, Michael Figa, Xiaoyan Zhao, Asim S. Siddiqui, Philip Ma, Sangtae Kim, Omid C. Farokhzad, Margaret Donovan, John E. Blume, Theodore Platt, Martin Goldberg, Damian Harris
  • Patent number: 12241899
    Abstract: Systems and methods for automated sample preparation and processing of protein corona are described herein, as well as its application in the discovery of advanced diagnostic tools as well as therapeutic agents.
    Type: Grant
    Filed: March 3, 2023
    Date of Patent: March 4, 2025
    Assignee: Seer, Inc.
    Inventors: William Manning, Young Kim, Brandon Kwan-Leong, Hope Liou, Xiaoyan Zhao, Daniel Hornburg, Martin Goldberg
  • Patent number: 12222349
    Abstract: Compositions, methods, and systems for analyzing the protein corona are described herein, as well as its application in the discovery of advanced diagnostic tools as well as therapeutic targets.
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: February 11, 2025
    Assignee: Seer, Inc.
    Inventors: Hongwei Xia, Lyndal Hesterberg, Michael Figa, Xiaoyan Zhao, Gregory Troiano, William Manning, John Blume, Omid Farokhzad, Matthew McLean, Craig Stolarczyk, Marwin Ko, Theodore Platt
  • Patent number: 12050222
    Abstract: Systems and methods for automated sample preparation and processing of protein corona are described herein, as well as its application in the discovery of advanced diagnostic tools as well as therapeutic agents.
    Type: Grant
    Filed: August 4, 2023
    Date of Patent: July 30, 2024
    Assignee: Seer, Inc.
    Inventors: William Manning, Young Kim, Brandon Kwan-Leong, Hope Liou, Xiaoyan Zhao, Daniel Hornburg, Martin Goldberg
  • Patent number: 11906526
    Abstract: Systems and methods for automated sample preparation and processing of protein corona are described herein, as well as its application in the discovery of advanced diagnostic tools as well as therapeutic agents.
    Type: Grant
    Filed: August 4, 2023
    Date of Patent: February 20, 2024
    Assignee: SEER, INC.
    Inventors: William Manning, Young Kim, Brandon Kwan-Leong, Hope Liou, Xiaoyan Zhao, Daniel Hornburg, Martin Goldberg
  • Patent number: 11630112
    Abstract: Systems and methods for automated sample preparation and processing of protein corona are described herein, as well as its application in the discovery of advanced diagnostic tools as well as therapeutic agents.
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: April 18, 2023
    Assignee: SEER, INC.
    Inventors: William Manning, Young Kim, Brandon Kwan-Leong, Hope Liou, Xiaoyan Zhao, Daniel Hornburg, Martin Goldberg
  • Patent number: 11428688
    Abstract: Compositions, methods, and systems for analyzing the protein corona are described herein, as well as its application in the discovery of advanced diagnostic tools as well as therapeutic targets.
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: August 30, 2022
    Assignee: SEER, INC.
    Inventors: Hongwei Xia, Lyndal Hesterberg, Michael Figa, Xiaoyan Zhao, Gregory Troiano, William Manning, John Blume, Omid Farokhzad, Matthew McLean, Craig Stolarczyk, Marwin Ko, Theodore Platt
  • Patent number: 10466230
    Abstract: A business method for use in classifying patient samples. The method includes steps of collecting case samples representing a clinical phenotypic state and control samples representing patients without said clinical phenotypic state. Preferably the system uses a mass spectrometry platform system to identify patterns of polypeptides in said case samples and in the control samples without regard to the specific identity of at least some of said polypeptides. Based on identified representative patterns of the state, the business method provides for the marketing of diagnostic products using representative patterns. The present invention relates to systems and methods for identifying new markers, diagnosing patients with a biological state of interest, and marketing/commercializing such diagnostics. The present invention relates to systems and methods of greater sensitivity, specificity, and/or cost effectiveness.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: November 5, 2019
    Assignee: Seer, Inc.
    Inventors: John T. Stults, Alfred Greenquist, Alexander Sassi